INTRODUCTION: Cardiovascular (CV) events represent a major cause of death in renal transplant patients [1, 2]. Renal transplant recipients also constitute a population at very high risk for progressive graft loss and renal events. Although immunological risk factors play an important role in renal survival, it is less recognized that hypertension is probably the major non-immunological risk factor for graft loss [2]. Accurate diagnosis of hypertension and adequate control of blood pressure (BP) is considered as a fundamental goal in the management of renal transplant patients in order to lower their CV and renal risk. However, diagnosis, treatment and monitoring of hypertension remain suboptimal in most renal transplant patients [3]. This editorial is a call for action aiming at improving hypertension control in the transplant population. [...]
Halimi, J.-M., Persu, A., Sarafidis, P. A., Burnier, M., Abramowicz, D., Sautenet, B., Oberbauer, R., Mallamaci, F., London, G., Rossignol, P., Wuerzner, G., Watschinger, B., & Zoccali, C. (2017). Optimizing hypertension management in renal transplantation: a call to action. Journal of Hypertension, 35(12), 2335-2338. https://doi.org/10.1097/HJH.0000000000001586 (Original work published 2017)